opinion Learnings from the unravelling of the Indian pharma industry The difference between industry-leading firms and the rest is the unrelenting focus of the leading ones on brand creation, production and supply chain processes, and product innovation. By Sudhanshu Nahta AND Saurabh Mukherjea
opinion What investors in India can learn from John Bogle Most Indian mutual funds underperform their benchmark. In these times, investors have much to learn from American investment guru John Bogle. By Saurabh Mukherjea
opinion The RBI can reverse the NBFC crisis A “voluntary asset quality review” of the top 50 NBFCs will reverse the ongoing crisis. By Saurabh Mukherjea
